Ai-assisted classical shadow tomography for molecular spectral properties

Technology
Conceptual
University

An AI-driven approach integrating generative models into Classical Shadow Tomography (CST) for efficient estimation of molecular spectral properties on quantum devices without classical methods.

Overview

This solution leverages AI to enhance Classical Shadow Tomography (CST) protocols for estimating molecular spectral properties. The integration of generative models enables efficient preparation of quantum states, estimating overlaps and expectation values between ground and excited states without the need for classical electronic structure methods. This approach aims to provide scalable and accurate quantum state property estimation while reducing resource intensity.

Technical specifications
  • AI Integration: Utilizes generative models like GFlowNets and Discrete-space Diffusion to optimize quantum circuit generation.
  • CST Protocols: Avoids full quantum state reconstruction by focusing on linear and non-linear operator estimation.
  • Efficient Sampling: Parallel sampling minimizes variance across estimators.
  • Focus on Molecular Spectral Properties: Direct estimation of overlaps and expectation values between ground and excited states.
Technology readiness level

The current technology readiness level is 2, indicating that the concept has been formulated and initial experiments are being conducted. The approach is undergoing validation with diatomic molecules and selected Hamiltonians, with further development planned for more complex chemical systems.


About McMaster University

McMaster University is a comprehensive, research‑intensive public university in Hamilton, Ontario, known for collaborative, problem‑driven scholarship and strong partnerships with healthcare and industry. A research and technology park adjacent to campus co‑locates corporate R&D with faculty labs, while an established engineering co‑op connects companies with talent and applied expertise. Deep integration with regional hospital systems enables clinical trials, real‑world evidence generation, and translational studies at scale. Research is supported by competitive funding from NSERC, CIHR, SSHRC, and the Canada Foundation for Innovation. A dedicated technology transfer office streamlines IP strategy, contracting, and commercialization for industry partners.

Halo home
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.